Proper Name: C1 Esterase Inhibitor (Human)
Manufacturer: ViroPharma Biologics LLC
- For routine prophylaxis against angioedema attacks in patients with Hereditary Angioedema (HAE).
- April 1, 2022 Approval Letter - CINRYZE
- June 20, 2018 Approval Letter - CINRYZE
- June 20, 2018 Summary Basis for Regulatory Action - CINRYZE
- Approval History, Letters, Reviews and Related Documents - CINRYZE
- Supporting Documents older than three years - CINRYZE